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The two authors in this section took a few moments to discuss the broader themes related 
to their research.  
 
One recurring theme is the content of the right to health and its relationship to notions of 
public health. There can be synergies or tensions between the approaches taken in these 
different areas, depending on how public health is approached.  
 
Another issue is how to understand the relationship between policy makers and scientists, 
and the evidential basis for decision-making. It arises, for instance, in discussions about 
triage and prioritisation of access to treatment. It is important to consider who is involved 
in devising responses to the pandemic. It is interesting, for instance to consider who has 
been involved in developing the different triage guidelines and what their role is vis-à-vis 
the state; typically this has been professional associations or government bodies with 
public health professional participation. In most instances there has been little input from 
communities of interest such as disability groups; groups representing the elderly or 
minority groups with a higher susceptibility to the disease and mortality rate. Despite the 
importance of inclusivity and participation, so far, the global human rights community has 
not engaged with these issues very closely.  
 
Science was understood, at least in principle, as a more effective, rational and more 
neutral, and less political or contentious, basis for decision-making. However, given the 
limited scientific knowledge about Covid-19, particularly in the first weeks and month after 
has also been difference of opinion among scientists and social scientists about some 
aspects of the most appropriate responses. Policy or decision-making needs to continually 
respond to emerging research and take account of different findings and views.  The triage 
yet conclusive or sufficiently probative, what are the guidelines actually based on? Also, 
scientific criteria can be used to hide ethically contentious decision-making. 
 
In terms of decisions about access to treatment or other interventions, there are difficult 
decisions that may arise where demand outstrips supply.  There are certain approaches 
which are clearly unjustifiable, because of their discriminatory nature. For instance, though 
the evidence points to the fact that certain minority groups, because of the social 
determinants of health, are more susceptible to contract the disease and less likely to 
they have a lesser likelihood to survive it. Yet, one could easily make the opposite 
argument that those groups should benefit from even greater access to treatment, a form 
some, it has been less problematic to deny treatment to persons over a certain age or with 
certain health conditions or disabilities, even though these denials would constitute other 
not, perhaps underscores our own limitations and limited capacity to be guided simply by 
instinct; involving communities of interest tends to be important in its own sake but also to 
serve as a counterbalance to the unconscious biases of those usually tasked with making 
policy and taking decisions.   
 
From a human rights perspective, one can be uncomfortable with some of the triage criteria 
(e.g., age; health prospects)  partly because of the problem of the limited participation of 
affected groups in the development of the policy. Indeed, why should doctors and ethicists 
be allowed to take these fundamental decisions about who will live or die? Clearly, 
communities of interest should have a right to be involved in decisions on public resource 
allocation. By involving communities of interest, there is a lesser likelihood to arrive at 
blanket, and probably unintended positions or decisions; it reduces the danger of 
unreasonable or inflexible policies.  
 
In conflict zones, the human rights community has not challenged prioritisations based on 
likely health outcomes for soldiers in need of treatment, and seems to defer to the medical 
or scientific community to determine who should receive treatment. Most soldiers will have 
similar health backgrounds (relatively young and healthy), which means triage decisions 
tend to focus exclusively or mainly on the likelihood that soldiers would survive treatment 
for battlefield injuries. Though even in this example, the decision will not necessarily be 
neutral, if for example decisions are also taken on the basis of the rank of the soldier. 
 
Beyond the procedural rights associated with access to decision-making, are there 
additional substantive components of the right to health which may assist us with our 
approach to prioritization of access to treatment? There has been limited articulation by 
scholars and advocates of how precisely the right to health applies during pandemics; 
despite the knowledge about the significant risk of a global pandemic. The Committee on 
 the right to health, provides 
a useful focus on positive health outcomes. Similarly, the right to health is relevant to 
states to actively and positively invest in health systems. Beyond the right to health, these 
thorny questions raise other human rights issues such as the right to non-discrimination 
and the right to life.  
 
It was obvious to the discussants that there are limitations associated with looking at issues 
from a single perspective; there are so many angles and complexities involved with these 
issues, many of them interlinked. And, maybe one of the most important lessons from the 
current pandemic is that discussion of these issues needs to continue in quieter times that 
make it possible to consider the many difficult issues with time for wide consultations. 
 
  
